Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

5.2K
Rous Sarcoma virus or RSV was discovered by F. Peyton Rous in the year 1911 as a filterable transmissible agent that could cause tumors in chickens. He won a Nobel Prize for this discovery in 1966. His experiments clearly demonstrated that some cancers could be caused by infectious agents and led to the discovery of many more cancer-causing viruses in animals as well as humans.
RSV is a retrovirus that contains two copies of a plus-strand  RNA genome. Its genome consists of four main open...
5.2K
Rous Sarcoma Virus (RSV) and Cancer01:03

Rous Sarcoma Virus (RSV) and Cancer

4.9K
4.9K
Cancer Therapies02:49

Cancer Therapies

8.1K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

C-Reactive Protein and Fibrinogen Dynamics Are Predictors of Reinfection Risk After Explantation in Two-Stage Periprosthetic Joint Revision.

The Journal of arthroplasty·2026
Same author

Antimicrobial resistance profiles in septic arthritis of native knee and shoulder joints from 2007 to 2024: a single center retrospective study.

Frontiers in medicine·2025
Same author

Surgical Site Infection in Patients Managed with an Endoprosthesis for the Treatment of Cancer: Evaluation of Patient, Disease, and Index Surgical Factors.

The Journal of bone and joint surgery. American volume·2023
Same author

High fibrinogen levels are associated with poor survival in patients with liposarcoma.

Scientific reports·2023
Same author

Quantitative and individualized assessment of the learning curve in preoperative planning of the acetabular cup size in primary total hip arthroplasty.

Archives of orthopaedic and trauma surgery·2021
Same author

The Dysregulated Galectin Network Activates NF-κB to Induce Disease Markers and Matrix Degeneration in 3D Pellet Cultures of Osteoarthritic Chondrocytes.

Calcified tissue international·2020
Same journal

Chronic Osteomyelitis - Pathophysiology and Treatment.

Zeitschrift fur Orthopadie und Unfallchirurgie·2026
Same journal

Posterior Malleolus Fractures of the Tibia: Open Reduction and Buttress Plating versus Percutaneous Fixation with an Anteroposterior Screw.

Zeitschrift fur Orthopadie und Unfallchirurgie·2026
Same journal

Ultrasound Assessment of Talar, Femoral and Metacarpal Cartilage Thicknesses in Hemiplegic Patients and their Relationship with Functional Parameters.

Zeitschrift fur Orthopadie und Unfallchirurgie·2026
Same journal

Current Concepts in Acute and Chronic Lateral Ankle Instability.

Zeitschrift fur Orthopadie und Unfallchirurgie·2026
Same journal

Zeitschrift fur Orthopadie und Unfallchirurgie·2026
Same journal

Zeitschrift fur Orthopadie und Unfallchirurgie·2026
See all related articles

Related Experiment Video

Updated: Apr 27, 2026

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

8.5K

[Soft tissue sarcoma].

J Panotopoulos1, P Funovics1, R Windhager1

  • 1Universitätsklinik für Orthopädie, Medizinische Universität Wien.

Zeitschrift Fur Orthopadie Und Unfallchirurgie
|June 25, 2014
PubMed
Summary
This summary is machine-generated.

Soft tissue sarcomas are rare connective tissue tumors. Accurate diagnosis and specialist multidisciplinary team management, including biopsy and tailored treatment, are crucial for patient outcomes.

More Related Videos

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

13.7K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

3.1K

Related Experiment Videos

Last Updated: Apr 27, 2026

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies
07:15

A Mouse Model of Incompletely Resected Soft Tissue Sarcoma for Testing Neoadjuvant Therapies

Published on: July 28, 2020

8.5K
Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma
07:55

Establishment of a Primary Culture of Patient-derived Soft Tissue Sarcoma

Published on: April 11, 2018

13.7K
Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors
08:57

Author Spotlight: Genetically Engineered Mouse Models and Pathological Characterization of Neurofibromatosis Type 1 Associated Tumors

Published on: May 17, 2024

3.1K

Area of Science:

  • Oncology
  • Pathology

Context:

  • Soft tissue sarcomas represent rare neoplastic diseases of connective tissue, with an incidence of approximately 3.6 per 100,000 individuals annually in Europe.
  • Accurate diagnostic knowledge of this rare entity is essential for effective patient management.
  • The rarity of soft tissue sarcomas necessitates specialized approaches to diagnosis and treatment.

Purpose:

  • To highlight the importance of accurate diagnosis and specialized management for soft tissue sarcomas.
  • To outline the current standard of care for soft tissue sarcomas.
  • To emphasize the role of a multidisciplinary team in managing these rare tumors.

Summary:

  • The primary treatment for soft tissue sarcomas involves wide surgical resection, potentially augmented by adjuvant radiation therapy.
  • Chemotherapy is a potential treatment option that requires individual case evaluation.
  • Biopsy is a critical prerequisite for all treatments and must align with the planned oncological resection strategy.

Impact:

  • Optimal management of soft tissue sarcomas requires a dedicated, specialist sarcoma multidisciplinary team.
  • Early and accurate diagnosis, coupled with appropriate treatment, can improve outcomes for patients with soft tissue sarcomas.
  • Standardized diagnostic and treatment protocols are vital for this rare oncological condition.